Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-2-28
pubmed:abstractText
M-phase Promoting Factor (MPF; the cyclin B-cdk 1 complex) is activated at M-phase onset by removal of inhibitory phosphorylation of cdk1 at thr-14 and tyr-15. At M-phase exit, MPF is destroyed by ubiquitin-dependent cyclin proteolysis. Thus, control of MPF activity via inhibitory phosphorylation is believed to be particularly crucial in regulating transition into, rather than out of, M-phase. Using the in vitro cell cycle system derived form Xenopus eggs, here we show, however, that inhibitory phosphorylation of cdk1 contributes to control MPF activity during M-phase exit. By sampling extracts at very short intervals during both meiotic and mitotic exit, we found that cyclin B1-associated cdk1 underwent transient inhibitory phosphorylation at tyr-15 and that cyclin B1-cdk1 activity fell more rapidly than the cyclin B1 content. Inhibitory phosphorylation of MPF correlated with phosphorylation changes of cdc25C, the MPF phosphatase, and physical interaction of cdk1 with wee1, the MPF kinase, during M-phase exit. MPF down-regulation required Ca(++)/calmodulin-dependent kinase II (CaMKII) and cAMP-dependent protein kinase (PKA) activities at meiosis and mitosis exit, respectively. Treatment of M-phase extracts with a mutant cyclin B1-cdk1AF complex, refractory to inhibition by phosphorylation, impaired binding of the Anaphase Promoting Complex/Cyclosome (APC/C) to its co-activator Cdc20 and altered M-phase exit. Thus, timely M-phase exit requires a tight coupling of proteolysis-dependent and proteolysis-independent mechanisms of MPF inactivation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-10799291, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-11030344, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-11516956, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-12049731, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-12477927, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-12651887, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-12852855, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-14517314, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-14561775, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-14712073, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-14731678, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-15107615, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-15970669, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-16096060, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-16122424, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-16139207, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-16195348, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-16287869, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-1836759, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-2147872, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-2566917, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-7937913, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-8232587, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-8428594, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-8596931, http://linkedlifedata.com/resource/pubmed/commentcorrection/17327911-9649427
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e247
pubmed:meshHeading
pubmed-meshheading:17327911-Animals, pubmed-meshheading:17327911-CDC2 Protein Kinase, pubmed-meshheading:17327911-Cell Cycle Proteins, pubmed-meshheading:17327911-Cyclin B1, pubmed-meshheading:17327911-Enzyme Activation, pubmed-meshheading:17327911-Female, pubmed-meshheading:17327911-Humans, pubmed-meshheading:17327911-Meiosis, pubmed-meshheading:17327911-Metaphase, pubmed-meshheading:17327911-Mitosis, pubmed-meshheading:17327911-Oocytes, pubmed-meshheading:17327911-Phosphorylation, pubmed-meshheading:17327911-Phosphothreonine, pubmed-meshheading:17327911-Phosphotyrosine, pubmed-meshheading:17327911-Protein Interaction Mapping, pubmed-meshheading:17327911-Protein Processing, Post-Translational, pubmed-meshheading:17327911-Protein-Tyrosine Kinases, pubmed-meshheading:17327911-Recombinant Fusion Proteins, pubmed-meshheading:17327911-Xenopus Proteins, pubmed-meshheading:17327911-Xenopus laevis, pubmed-meshheading:17327911-cdc25 Phosphatases
pubmed:year
2007
pubmed:articleTitle
Role for non-proteolytic control of M-phase-promoting factor activity at M-phase exit.
pubmed:affiliation
Faculty of Biotechnological Sciences and Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, University of Napoli Federico II, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't